Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026

Go back to Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026
(NASDAQ: KRYS) Delayed: 339.93 -3.5 (1.02%)
Previous Close $343.43    52 Week High
Open $339.21    52 Week Low
Day High $346.82    P/E N/A 
Day Low $337.60    EPS
Volume 135,822